Advanced search
1 file | 1.26 MB

Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia

Author
Organization
Abstract
Several B. cenocepacia mouse models are available to study the pulmonary infection by this Burkholderia cepacia complex (BCC) species. However, a characterized B. cenocepacia mouse model to evaluate the efficacy of potential new antibacterial therapies is not yet described. Therefore, we optimized and validated the course of infection (Le. bacterial proliferation in lung, liver and spleen) and the efficacy of a reference antibiotic, tobramycin (TOB), in a mouse lung infection model. Furthermore, the local immune response and histological changes in lung tissue were studied during infection and treatment. A reproducible lung infection was observed when immunosuppressed BALB/c mice were infected with B. cenocepacia LMG 16656. Approximately 50 to 60% of mice infected with this BCC species demonstrated a dissemination to liver and spleen. TOB treatment resulted in a two log reduction in lung burden, prevented dissemination of B. cenocepacia to liver and spleen and significantly reduced levels of proinflammatory cytokines. As this mouse model is characterized by a reproducible course of infection and efficacy of TOB, it can be used as a tool for the in vivo evaluation of new antibacterial therapies.
Keywords
CYSTIC-FIBROSIS PATIENTS, CEPACIA COMPLEX, CYCLOPHOSPHAMIDE, ANTIBIOTICS, RESISTANCE, MICE, TRANSPLANTATION, PERSISTENCE, STRATEGIES, INVASION, Burkholderia cenocepacia, Mouse model, Pneumonia, Tobramycin

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.26 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Vanhoutte, Bieke, Davie Cappoen, Bidart de Macedo Maira, Freya Cools, Eveline Torfs, Tom Coenye, Wim Martinet, et al. 2017. “Optimization and Characterization of a Murine Lung Infection Model for the Evaluation of Novel Therapeutics Against Burkholderia Cenocepacia.” Journal of Microbiological Methods 139: 181–188.
APA
Vanhoutte, Bieke, Cappoen, D., Maira, B. de M., Cools, F., Torfs, E., Coenye, T., Martinet, W., et al. (2017). Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia. JOURNAL OF MICROBIOLOGICAL METHODS, 139, 181–188.
Vancouver
1.
Vanhoutte B, Cappoen D, Maira B de M, Cools F, Torfs E, Coenye T, et al. Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia. JOURNAL OF MICROBIOLOGICAL METHODS. 2017;139:181–8.
MLA
Vanhoutte, Bieke et al. “Optimization and Characterization of a Murine Lung Infection Model for the Evaluation of Novel Therapeutics Against Burkholderia Cenocepacia.” JOURNAL OF MICROBIOLOGICAL METHODS 139 (2017): 181–188. Print.
@article{8542892,
  abstract     = {Several B. cenocepacia mouse models are available to study the pulmonary infection by this Burkholderia cepacia complex (BCC) species. However, a characterized B. cenocepacia mouse model to evaluate the efficacy of potential new antibacterial therapies is not yet described. Therefore, we optimized and validated the course of infection (Le. bacterial proliferation in lung, liver and spleen) and the efficacy of a reference antibiotic, tobramycin (TOB), in a mouse lung infection model. Furthermore, the local immune response and histological changes in lung tissue were studied during infection and treatment. A reproducible lung infection was observed when immunosuppressed BALB/c mice were infected with B. cenocepacia LMG 16656. Approximately 50 to 60% of mice infected with this BCC species demonstrated a dissemination to liver and spleen. TOB treatment resulted in a two log reduction in lung burden, prevented dissemination of B. cenocepacia to liver and spleen and significantly reduced levels of proinflammatory cytokines. As this mouse model is characterized by a reproducible course of infection and efficacy of TOB, it can be used as a tool for the in vivo evaluation of new antibacterial therapies.},
  author       = {Vanhoutte, Bieke and Cappoen, Davie and Maira, Bidart de Macedo and Cools, Freya and Torfs, Eveline and Coenye, Tom and Martinet, Wim and Caljon, Guy and Maes, Louis and Delputte, Peter and Cos, Paul},
  issn         = {0167-7012},
  journal      = {JOURNAL OF MICROBIOLOGICAL METHODS},
  keywords     = {CYSTIC-FIBROSIS PATIENTS,CEPACIA COMPLEX,CYCLOPHOSPHAMIDE,ANTIBIOTICS,RESISTANCE,MICE,TRANSPLANTATION,PERSISTENCE,STRATEGIES,INVASION,Burkholderia cenocepacia,Mouse model,Pneumonia,Tobramycin},
  language     = {eng},
  pages        = {181--188},
  title        = {Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia},
  url          = {http://dx.doi.org/10.1016/j.mimet.2017.06.003},
  volume       = {139},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: